genetics

Companies tracking mutations in cancer cells can provide a key to unlocking better therapies

Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can creat

Hospital in China denies links to world’s first gene-edited babies

News of the world’s first-ever gene-edited human babies being born in China caused a huge stir on Monday after the MIT Technology Review and the Associated Press brought the project to ligh

Synthego raises $110 million to make gene editing technologies more accessible

Paul Dabrowski, the chief executive officer of Synthego, which provides genetically engineered cells to scientists and researchers, worries about a future where access to the genetic technologies that

23andMe might soon offer a more comprehensive $749 DNA service

23andMe is testing a $749 “premium” service for deeper health insights, according to several customers who saw a test page for the new product and posted about it on Reddit. First spotted

George Church’s genetics on the blockchain startup just raised $4.3 million from Khosla

Nebula Genomics, the startup that wants to put your whole genome on the blockchain, has announced the raise of $4.3 million in Series A from Khosla Ventures and other leading tech VC’s such as 

Helix holds first close on a planned $200 million investment in its genetic services marketplace

Welcome to the future… where startups are willing to customize everything from a diet regimen to a workout plan, or family planning to personal fashion based on an individual’s genetic c

Human sequencing pioneer George Church wants to give you the power to sell your DNA on the blockchain

The blockchain is the buzziest thing on the internet these days and now MIT professor and godfather of the Human Genome Project George Church wants to put your genes on it. His new startup Nebula Geno

23andMe’s second act sits squarely in drug research and development

The company first began making moves early in 2015, forging a partnership with Pfizer to conduct a bit of drug research using 23andMe’s genetic data. The pact was formed in the midst of orders f

WuXi NextCODE aims for the genomics database “gold standard” with new $240 million

A lot of money is being poured into genomics lately, including the genomic information company WuXi NextCODE (WXNC), which just announced it has closed on $240 million in Series B financing, led by Se

EverlyWell rolls out three new DNA-based products for food sensitivity, metabolism and breast milk

There's a lot going on in commercial DNA testing these days beyond what eye color you have or where your mitochondria comes from, and at-home lab testing startup EverlyWell hopes to cash in. The start

Scientists have eliminated HIV in mice using CRISPR

An important breakthrough has been made in the eradication of AIDs. Scientists have found they can successfully snip out the HIV virus from mouse cells using CRISPR/Cas9 technology.

Early cancer detection startup GRAIL closes on $900 million in Series B funding

Life sciences startups need a whole lot more cash than most and that’s certainly true for GRAIL, a cancer detection startup trying to figure out a way to find the “emperor of all maladies&

Illumina wants to sequence your whole genome for $100

The first sequencing of the whole human genome in 2003 cost roughly $2.7 billion, but DNA sequencing giant Illumina has now unveiled a new machine that the company says is “expected one day&#822

Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

Researchers at North Carolina-based Locus Biosciences think they have a potential cure for antibiotic resistance using CRISPR’s lesser-known Cas3 enzyme. Most of the interest in CRISPR technolog

Chinese scientists CRISPR a human for the first time

A group of Chinese scientists injected a human being with cells genetically edited using CRISPR-Cas9 technology. This is the first time CRISPR has been used on a fully formed adult human and it&#8217

Oral arguments for who owns CRISPR-Cas9 start next month

The date has been set for oral arguments to begin over who owns the patent rights to the gene-editing wonder CRISPR-Cas9. Berkeley’s Jennifer Doudna and her colleague from the Max Planck Institu

Genetics startup Genos wants to pay you for your DNA data

The first whole human genome sequencing cost a whopping $2.7 billion. That didn’t bode well for making any breakthroughs on genetic disorders. Luckily, the cost has dropped dramatically since t

Gut health startup uBiome has raised $15.5 million and is launching a DNA test for your poop

There are a lot of startups looking at your DNA these days but uBiome stands out as unique among them for testing the DNA of microorganisms found in your fecal matter. These bugs have a lot to do with

23andMe reportedly no longer working on next-gen sequencing

23andMe won’t continue with next-generation DNA sequencing and has reportedly laid off the lab working on the project. About half-a-dozen workers were laid off from the Salt Lake City, Utah-base

23andMe’s Anne Wojcicki has a plan to include better genetic data from people of color

One of the first consumer genetic testing companies, 23andMe says it aims to be at the forefront in gathering genetically diverse data throughout the world. The company just launched a standalone $99
Load More